Nutex Health Inc. (NUTX)
NASDAQ: NUTX · Real-Time Price · USD
160.95
+4.16 (2.65%)
At close: Dec 5, 2025, 4:00 PM EST
162.01
+1.06 (0.66%)
After-hours: Dec 5, 2025, 7:59 PM EST
Nutex Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Revenue | 981.2 | 479.95 | 247.65 | 219.29 | 331.53 | 274.03 | Upgrade
|
| Revenue Growth (YoY) | 236.03% | 93.80% | 12.93% | -33.85% | 20.98% | 182.34% | Upgrade
|
| Cost of Revenue | 420.8 | 264.72 | 195.28 | 190.74 | 144.59 | 104.56 | Upgrade
|
| Gross Profit | 560.39 | 215.23 | 52.37 | 28.55 | 186.94 | 169.47 | Upgrade
|
| Selling, General & Admin | 46.58 | 41.92 | 33.23 | 19.81 | 5.46 | 10.4 | Upgrade
|
| Operating Expenses | 201.41 | 77.45 | 53.66 | 33.13 | 13.12 | 16.29 | Upgrade
|
| Operating Income | 358.98 | 137.78 | -1.29 | -4.58 | 173.82 | 153.17 | Upgrade
|
| Interest Expense | -22.3 | -19.93 | -16.32 | -12.49 | -6.2 | -6.43 | Upgrade
|
| Other Non Operating Income (Expenses) | -9.15 | -0.94 | -0.4 | -0.56 | -0.12 | -1 | Upgrade
|
| EBT Excluding Unusual Items | 327.53 | 116.91 | -18.01 | -17.63 | 167.5 | 145.74 | Upgrade
|
| Merger & Restructuring Charges | -3.89 | -3.89 | -29.34 | -3.89 | -3.55 | - | Upgrade
|
| Impairment of Goodwill | -0 | -3.2 | -1.14 | -398.14 | - | - | Upgrade
|
| Other Unusual Items | - | - | - | - | 5.55 | - | Upgrade
|
| Pretax Income | 327.54 | 109.83 | -48.49 | -419.65 | 169.49 | 145.74 | Upgrade
|
| Income Tax Expense | 64.29 | 15.02 | -5.07 | 13.09 | 0.97 | 0.18 | Upgrade
|
| Earnings From Continuing Operations | 263.25 | 94.81 | -43.42 | -432.74 | 168.53 | 145.56 | Upgrade
|
| Minority Interest in Earnings | -142.68 | -42.71 | -2.36 | 7.96 | -35.93 | -39.59 | Upgrade
|
| Net Income | 120.57 | 52.1 | -45.79 | -424.78 | 132.59 | 105.97 | Upgrade
|
| Net Income to Common | 120.57 | 52.1 | -45.79 | -424.78 | 132.59 | 105.97 | Upgrade
|
| Net Income Growth | - | - | - | - | 25.12% | 406.47% | Upgrade
|
| Shares Outstanding (Basic) | 6 | 5 | 4 | 4 | 4 | 4 | Upgrade
|
| Shares Outstanding (Diluted) | 7 | 5 | 4 | 4 | 4 | 4 | Upgrade
|
| Shares Change (YoY) | 40.46% | 24.57% | 4.15% | 7.10% | - | - | Upgrade
|
| EPS (Basic) | 20.25 | 10.23 | -10.39 | -100.36 | 33.55 | 26.81 | Upgrade
|
| EPS (Diluted) | 17.98 | 9.69 | -10.39 | -100.36 | 33.00 | 26.81 | Upgrade
|
| EPS Growth | - | - | - | - | 23.07% | - | Upgrade
|
| Free Cash Flow | 174.28 | 20.85 | -8.24 | 35.97 | 136.51 | 25.48 | Upgrade
|
| Free Cash Flow Per Share | 25.58 | 3.80 | -1.87 | 8.50 | 34.54 | 6.45 | Upgrade
|
| Gross Margin | 57.11% | 44.84% | 21.14% | 13.02% | 56.39% | 61.84% | Upgrade
|
| Operating Margin | 36.59% | 28.71% | -0.52% | -2.09% | 52.43% | 55.90% | Upgrade
|
| Profit Margin | 12.29% | 10.85% | -18.49% | -193.70% | 39.99% | 38.67% | Upgrade
|
| Free Cash Flow Margin | 17.76% | 4.34% | -3.33% | 16.41% | 41.17% | 9.30% | Upgrade
|
| EBITDA | 379.61 | 156.75 | 16.3 | 8.55 | 181.48 | 159.07 | Upgrade
|
| EBITDA Margin | 38.69% | 32.66% | 6.58% | 3.90% | 54.74% | 58.05% | Upgrade
|
| D&A For EBITDA | 20.62 | 18.97 | 17.59 | 13.13 | 7.66 | 5.9 | Upgrade
|
| EBIT | 358.98 | 137.78 | -1.29 | -4.58 | 173.82 | 153.17 | Upgrade
|
| EBIT Margin | 36.59% | 28.71% | -0.52% | -2.09% | 52.43% | 55.90% | Upgrade
|
| Effective Tax Rate | 19.63% | 13.68% | - | - | 0.57% | 0.12% | Upgrade
|
| Revenue as Reported | 981.2 | 479.95 | 247.65 | 219.29 | 331.53 | 274.03 | Upgrade
|
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.